Edyta Zielinska | Sep 27, 2010 | 3 min read
linkurl:1. Diabetes drug details unveiled;http://bit.ly/9UllVV Researchers uncovered the details of how a common diabetes treatment works -- by blocking the phosphorylation of a master regulator of fat development, thereby suppressing the activation of genes that promote insulin insensitivity -- providing clues that may help reduce side effects, such as weight gain. J.H. Choi et al., "Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5," linkurl:__Nature,__;http: